Literature DB >> 15188708

Amino-acid change on the antigenic region B1 of H3 haemagglutinin may be a trigger for the emergence of drift strain of influenza A virus.

K Sato1, T Morishita, E Nobusawa, K Tonegawa, K Sakae, S Nakajima, K Nakajima.   

Abstract

Sera from 27 children and eight older persons, which had been collected in 1998 and 1999 and showed haemagglutination-inhibition (HI) activity against influenza A/Sydney/5/97 (H3N2) strain, were characterized with a binding assay using chimeric haemagglutinin (HA) proteins between A/Aichi/2/68 (A/AI/68) and A/Sydney/5/97 (A/SD/97) strains. Sera from the young children had a tendency to recognize only the antigenic site B1 of the HA1 region. On the other hand, sera of the older individuals were fully reactive to all antigenic sites of HA1 except antigenic site D. Recent epidemic strains, A/Panama/2007/99 (A/PM/99)-like viruses have differences in amino acids in antigenic sites A, C, and B2 but not B1. However, human antisera obtained even from young children had HI activity to Panama-like viruses. The limited epidemic of A/PM/99-like viruses may have been due to the existence of antibody against B1, which had been produced in response to infection by the A/SD/97-like viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188708      PMCID: PMC2870118          DOI: 10.1017/s0950268803001821

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

1.  Host immunity and pathogen diversity: A computational study.

Authors:  Tomás Aquino; Ana Nunes
Journal:  Virulence       Date:  2016       Impact factor: 5.882

Review 2.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

3.  Accumulation of amino acid substitutions promotes irreversible structural changes in the hemagglutinin of human influenza AH3 virus during evolution.

Authors:  Katsuhisa Nakajima; Eri Nobusawa; Alexander Nagy; Setsuko Nakajima
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.

Authors:  Feng Liu; Vic Veguilla; F Liaini Gross; Eric Gillis; Thomas Rowe; Xiyan Xu; Terrence M Tumpey; Jacqueline M Katz; Min Z Levine; Xiuhua Lu
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

5.  Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition.

Authors:  Sarah Cobey; Mercedes Pascual
Journal:  J Theor Biol       Date:  2010-11-18       Impact factor: 2.691

6.  Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread.

Authors:  Shelly Gulati; David F Smith; Richard D Cummings; Robert B Couch; Sara B Griesemer; Kirsten St George; Robert G Webster; Gillian M Air
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  Why do adaptive immune responses cross-react?

Authors:  Karen J Fairlie-Clarke; David M Shuker; Andrea L Graham
Journal:  Evol Appl       Date:  2008-12-08       Impact factor: 5.183

Review 8.  Influenza immune escape under heterogeneous host immune histories.

Authors:  Rachel J Oidtman; Philip Arevalo; Qifang Bi; Lauren McGough; Christopher Joel Russo; Diana Vera Cruz; Marcos Costa Vieira; Katelyn M Gostic
Journal:  Trends Microbiol       Date:  2021-07-01       Impact factor: 17.079

9.  The antigenic evolution of influenza: drift or thrift?

Authors:  Paul S Wikramaratna; Michi Sandeman; Mario Recker; Sunetra Gupta
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

10.  Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.

Authors:  Lyubov Popova; Kenneth Smith; Ann H West; Patrick C Wilson; Judith A James; Linda F Thompson; Gillian M Air
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.